Enhancing both oral bioavailability and brain penetration of puerarin using borneol in combination with preparation technologies

References

• Brewster ME, Loftsson T, Bodor N. (2004). Applications of chemically-modified cyclodextrins: use of hydroxypropyl-β-cyclodextrin as an enabling excipient for brain targeting, redox-based derivatives of estradiol: a review of preclinical and clinical findings. J Drug Deliv Sci Technol 14:21–34
   Web of Science ®Google Scholar
• Cai Z, Lei XL, Lin ZF, et al. (2014). Preparation and evaluation of sustained-release solid dispersions co-loading gastrodin with borneol as an oral brain-targeting enhancer. Acta Pharmaceutica Sinica B 4:86–93
   PubMed Web of Science ®Google Scholar
• Chen XH. (2010). Analysis of 266 cases of ADRs induced by puerarin injection. Shanxi Zhongyi 24:203–5
   Google Scholar
• Chen YM, Wang NS. (2003). Effect of borneol on P-glycoprotein. Tradit Chin Drug Res Pharmacol 14:96–9
   Google Scholar
• Chen ZZ, Lu Y, Du SY, et al. (2013). Influence of borneol and muscone on geniposide transport through MDCK and MDCK-MDR1 cells as blood-brain barrier in vitro model. Int J Pharm 456:73–9
   PubMed Web of Science ®Google Scholar
• Choo MK, Park EK, Yoon HK, et al. (2002). Antithrombotic and antiallergic activities of daidzein, a metabolite of puerarin and daidzin produced by human intestinal microflora. Biol Pharm Bull 25:1328–32
   PubMed Web of Science ®Google Scholar
• Cui SM, Zhao CS, He ZG. (2007). Uptaking characteristics of puerarin in Caco-2 model system. Chin Tradit Herbal Drugs 38:836–9
   Google Scholar
• Dong XP, Ruan M, Yu B, et al. (2012). Effects of borneol at different doses on concentration of geniposide in rat brains. Chinese Trad Herbal Drugs 43:1366–70
   Google Scholar
• He HJ, Shen Q, Li J. (2011). Effects of borneol on the intestinal transport and absorption of two P-glycoprotein substrates in rats. Arch Pharm Res 34:1161–70
   PubMed Web of Science ®Google Scholar
• Jeulin H, Venard V, Carapito D, et al. (2009). Effective ribavirin concentration in mice brain using cyclodextrin as a drug carrier: evaluation in a measles encephalitis model. Antiviral Res 81:261–6
   PubMed Web of Science ®Google Scholar
• Lai XJ, Zhang L, Li JS, et al. (2011). Comparative pharmacokinetic and bioavailability studies of three salvianolic acids after the administration of Salviae miltiorrhizae alone or with synthetical borneol in rats. Fitoterapia 82:883–8
   PubMed Web of Science ®Google Scholar
• Li HW, Dong L, Liu Y, et al. (2014). Biopharmaceutics classification of puerarin and comparison of perfusion approaches in rats. Int J Pharm 466:133–8
   PubMed Web of Science ®Google Scholar
• Li M, Si L, Pan H, et al. (2011). Excipients enhance intestinal absorption of ganciclovir by P-gp inhibition: assessed in vitro by everted gut sac and in situ by improved intestinal perfusion. Int J Pharm 403:37–45
   PubMed Web of Science ®Google Scholar
• Li X, Mao YL, Li K, et a l. (2016). Pharmacokinetics and tissue distribution study in mice of triptolide-loaded lipid emulsion and accumulation effect on pancreas. Drug Deliv 23:1344–54
   PubMed Web of Science ®Google Scholar
• Liu BG, Zhao J, Liu YH, et al. (2012). Physicochemical properties of the inclusion complex of puerarin and glucosyl-beta-cyclodextrin. J Agric Food Chem 60:12501–7
   PubMed Web of Science ®Google Scholar
• Luo CF, Yuan M, Chen MS. (2011). Pharmacokinetics tissue distribution and relative bioavailability of puerarin solid lipid nanoparticles following oral administration. Int J Pharm 410:138
   PubMed Web of Science ®Google Scholar
• Ma QM. (2010). The discussion on adverse reaction of puerarin injection. Asia-Pacific Traditional Mwdicine 6:182–3
   Google Scholar
• Ren JG, Zou MJ, Gao P, et al. (2013). Tissue distribution of borneol-modified ganciclovir-loaded solid lipid nanoparticles in mice after intravenous administration. Eur J Pharm Biopharm 83:141–8
   PubMed Web of Science ®Google Scholar
• Rezazadeh M, Emami J, Hasanzadeh F, et al. (2016). In vivo pharmacokinetics, biodistribution and anti-tumor effect of paclitaxel-loaded targeted chitosan-based polymeric micelle. Drug Deliv 23:1707–17
   PubMed Web of Science ®Google Scholar
• Tang DD, Li N, Wang LW, et al. (2014). Impact of drug molecules on HP-β-CD compound inclusion. Chin J Chin Mater Med 39:2893–9
   Google Scholar
• Tang TT, Hu XB, Liao DH, et al. (2013). Mechanisms of microemulsion enhancing the oral bioavailability of puerarin: comparison between oil-in-water and water-in-oil microemulsions using the single-pass intestinal perfusion method and a chylomicron flow blocking approach. Int J Nanomedicine 8:4415–26
   PubMed Web of Science ®Google Scholar
• Tao HQ, Meng QF, Li MH, et al. (2013). HP-β-CD-PLGA nanoparticles improve the penetration and bioavailability of puerarin and enhance the therapeutic effects on brain ischemia–reperfusion injury in rats. Naunyn Schmiedebergs Arch Pharmacol 386:61–70
   PubMed Web of Science ®Google Scholar
• Tilloy S, Monnaert V, Fenart L, et al. (2006). Methylated beta-cyclodextrin as P-gp modulators for deliverance of doxorubicin across an in vitro model of blood-brain barrier. Bioorg Med Chem Lett 16:2154–7
   PubMed Web of Science ®Google Scholar
• Tu LX, Yi YN, Wu W, et al. (2013). Effects of particle size on the pharmacokinetics of puerarin nanocrystals and microcrystals after oral administration to rat. Int J Pharm 458:135–40
   PubMed Web of Science ®Google Scholar
• Vecsernyés M, Fenyvesi F, Bácskay I, et al. (2014). Cyclodextrins, blood-brain barrier, and treatment of neurological diseases. Arch Med Res 45:711–29
   PubMed Web of Science ®Google Scholar
• Wang N, Zhang YM, Wu L, et al. (2014). Puerarin protected the brain from cerebral ischemia injury via astrocyte apoptosis inhibition. Neuropharmacology 79:282–9
   PubMed Web of Science ®Google Scholar
• Wang Q. Pharmacokinetic study of zige freeze-dried powder and mechanism study of improving permeability of BBB[D]. Chongqing: Southwest University; 2012
   Google Scholar
• Wei SY, Chen Y, Xu XY. (2014). Progress on the pharmacological research of puerarin: a review. Chin J Nat Med 12:407–14
   PubMed Web of Science ®Google Scholar
• Wu B, Liu M, Liu H, et al. (2007). Meta-analysis of traditional Chinese patent medicine for ischemic stroke. Stroke 38:1973–9
   PubMed Web of Science ®Google Scholar
• Wu HF, Zhou A, Lu CH, et al. (2011). Examination of lymphatic transport of puerarin in unconscious lymph duct-cannulated rats after administration in microemulsion drug delivery systems. Eur J Pharm Sci 42:348–53
   PubMed Web of Science ®Google Scholar
• Xiao YY, Ping QN, Chen ZP. (2007). The enhancing effect of synthetical borneol on the absorption of tetramethylpyrazine phosphate in mouse. Int J Pharm 337:74–9
   PubMed Web of Science ®Google Scholar
• Xue Q, Liu Y, Qi HY, et al. (2013). A novel brain neurovascular unit model with neurons, astrocytes and microvascular endothelial cells of rat. Int J Biol Sci 9:174–89
   PubMed Web of Science ®Google Scholar
• Yan LP, Zhuang YL, Chan SW, et al. (2009). Analysis of the mechanisms underlying the endothelium-dependent antivasoconstriction of puerarin in rat aorta. Naunyn Schmiedebergs Arch Pharmacol 379:587–97
   PubMed Web of Science ®Google Scholar
• Yi YN, Tu LX, Hu KL, et al. (2015). The construction of puerarin nanocrystals and its pharmacokinetic and in vivo-in vitro correlation (IVIVC) studies on beagle dog. Colloids Surf B Biointerfaces 133:164–70
   PubMed Web of Science ®Google Scholar
• You XH, Xing Q, Tuo J, et al. (2014). Optimizing surfactant content to improve oral bioavailability of ibuprofen in microemulsions: just enough or more than enough? Int J Pharm 471:276–84
   PubMed Web of Science ®Google Scholar
• Yu B, Ruan M, Dong XP, et al. (2013). The mechanism of the opening of the blood–brain barrier by borneol: a pharmacodynamics and pharmacokinetics combination study. J Ethnopharmacol 150:1096–108
   PubMed Web of Science ®Google Scholar
• Yu B, Ruan M, Cui XB, et al. (2013). Effects of borneol on the pharmacokinetics of geniposide in cortex, hippocampus, hypothalamus and striatum of conscious rat by simultaneous brain microdialysis coupled with UPLC-MS. J Pharm Biomed Anal 77:128–32
   PubMed Web of Science ®Google Scholar
• Zhang HY, Wei F, Cong L, et al. (2010). Investigation of the inclusions of puerarin and daidzin with beta-cyclodextrin by molecular dynamics simulation. J Phys Chem B 114:4876–83
   PubMed Web of Science ®Google Scholar
• Zhang Q, Wu D, Wu J, et al. (2015). Improved blood-brain barrier distribution: effect of borneol on the brain pharmacokinetics of kaempferol in rats by in vivo microdialysis sampling. J Ethnopharmacol 162:270–7
   PubMed Web of Science ®Google Scholar
• Zhang X, Xiong J, Liu S, et al. (2014). Puerarin protects dopaminergic neurons in Parkinson’s disease models. Neuroscience 280:88–98
   PubMed Web of Science ®Google Scholar
• Zirar SB, Astier A, Muchow M, et al. (2008). Comparison of nanosuspensions and hydroxypropyl-beta-cyclodextrin complex of melarsoprol: pharmacokinetics and tissue distribution in mice. Eur J Pharm Biopharm 70:649–56
   PubMed Web of Science ®Google Scholar